Equities researchers at StockNews.com initiated coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the stock. Oragenics Stock Down 4.5 % NYSE:OGEN opened at $1.27 on Monday. The firm has a market cap of $5.69 million, a P/E ratio of […]